Cargando…
2407. Emerging Piperacillin/Tazobactam Resistance in Escherichia coli and Klebsiella sp.
BACKGROUND: Piperacillin / tazobactam (P/T) plays an important role in the empirical therapy of many infections. While Enterobacteraciae resistance to P/T remains relatively low in our institution we have identified an increasing number of E. coli and Klebsiella sp. isolates with intermediate suscep...
Autores principales: | Suseno, Mira, Das, Sanchita, Semel, Jeffery, Thomson, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253293/ http://dx.doi.org/10.1093/ofid/ofy210.2060 |
Ejemplares similares
-
Rapid Detection of Piperacillin-Tazobactam Resistance in Klebsiella pneumoniae and Escherichia coli
por: Ortiz de la Rosa, José Manuel, et al.
Publicado: (2023) -
1061. Decreased Utilization of Piperacillin–Tazobactam for Escherichia coli and Klebsiella Bacteremia due to Selective Susceptibility Reporting
por: Zahlanie, Yorgo, et al.
Publicado: (2019) -
1414. Inoculum Effect of Piperacillin/Tazobactam Concentration on Emergence of Resistance in Klebsiella aerogenes
por: Custodio, Marco, et al.
Publicado: (2018) -
2290. Carbapenem vs. Piperacillin–tazobactam Definitive Therapy for Patients with Bloodstream Infections Due to Ceftriaxone Not Susceptible Escherichia coli or Klebsiella species
por: MacVane, Shawn H, et al.
Publicado: (2019) -
Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia
por: Zahlanie, Yorgo, et al.
Publicado: (2021)